JPMorgan’s Aug 4, 2026 note making the rare move to downgrade Nike to Underweight and cut the price target to $40 from $47 has produced an immediate market reaction - shares fell about 3.11% in pre-market trading to $41.32. The bank’s revision rests on the view that Nike’s recent strategic choices will depress earnings well into fiscal 2028, rather than delivering a quick recovery.
The numbers JPMorgan is using
- FY27 EPS: $1.55 - roughly 10% below Street consensus.
- FY28 EPS: $1.72 - roughly 20% below Street consensus.
- China online reset (effective January 2027): estimated greater than $1 billion in annual revenue headwind, about 20% of the region’s revenue.
- North America: store closures are expected to create a headwind that persists through the first half of FY28.
How the wider Street sees Nike
JPMorgan’s stance diverges sharply from much of the analyst community. The consensus remains skewed toward Buy and Hold ratings. Selected price targets and valuations cited across brokers include values in the mid-60s to 90s, with examples such as Morgan Stanley at $72, Bernstein at $68, Barclays at $65, RBC Capital Markets at $90 and KeyBanc at $90. InvestingPro’s fair value estimate of $58.08 implies about 36% upside from current levels. Overall, the consensus count stands at 12 Buy ratings, 25 Hold ratings and 2 Sell ratings.
Evidence that boosts JPMorgan’s case
JPMorgan’s bearish view is supported by survey and partnership signals that point to structural challenges. A Morgan Stanley intern survey cited on the same morning showed Nike losing athletic footwear preference share for the fifth straight year, reaching the lowest level recorded by that survey, while On Holding (ONON) posted the largest year-over-year share gain. Separately, Nike is ending its longstanding online partnership with Topsports (ticker 6110) in China after 27 years, a decision JPMorgan characterizes as creating structural revenue disruption beginning January 2027.
Bull and bear outlines
- Bull case: A fair value around $58.08 suggests significant upside from prevailing prices. Supporters point to CEO Elliott Hill’s "Win Now" and "Sport Offense" initiatives as credible multi-year restructuring, a 23-year dividend streak that remains intact, and the potential for a November investor day to present a three-year plan targeting double-digit operating margins by FY30 that could re-rate the stock.
- Bear case: Recent results show revenue down 12% year-over-year with digital sales down 26% year-over-year, a deteriorating China performance, and faster brand fragmentation. JPMorgan’s EPS projections for FY28 are about 20% below Street consensus, a gap that raises the possibility the market is overly optimistic about a recovery.
Why JPMorgan could be right - and how it could be wrong
JPMorgan’s position is not without merit. The projected China online reset translating into a greater than $1 billion hole beginning January 2027 and North American retail pressure are tangible, quantifiable hits to revenue and margins. Those elements form the backbone of JPMorgan’s case that earnings will be constrained into fiscal 2028.
Yet JPMorgan stands amid a heavy stream of more optimistic target prices and Buy/Hold opinions. That divergence means the bank can be wrong if Nike’s restructuring and operational actions produce a quicker or stronger recovery than JPMorgan projects. At a pre-market price of $41.32, the stock sits near JPMorgan’s $40 target, suggesting that much of the downside JPMorgan anticipates may already be reflected in the share price.
The near-term catalyst to watch
Market participants will look to Nike’s November investor day as the next material event. If the company lays out a credible three-year roadmap and a path to the double-digit operating margin targets management describes, analysts leaning toward JPMorgan’s view could be prompted to revise their estimates upward. Conversely, if the investor day fails to assuage concerns about China, digital disruption and North America retail dynamics, JPMorgan’s downgrade may prove prescient.